ONFI
Drug
Lundbeck LLC
Total Payments
$1.6M
Transactions
12,867
Doctors
3,130
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $24.91 | 1 | 1 |
| 2022 | $1.71 | 1 | 1 |
| 2020 | $28,783 | 2 | 1 |
| 2019 | $138,544 | 12 | 8 |
| 2018 | $437,450 | 4,409 | 1,693 |
| 2017 | $1.0M | 8,442 | 2,569 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $838,638 | 682 | 51.6% |
| Unspecified | $379,364 | 10 | 23.3% |
| Food and Beverage | $240,965 | 11,656 | 14.8% |
| Travel and Lodging | $138,436 | 463 | 8.5% |
| Consulting Fee | $25,438 | 17 | 1.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,420 | 3 | 0.1% |
| Education | $143.28 | 36 | 0.0% |
Payments by Type
General
$1.2M
12,857 transactions
Research
$379,364
10 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| N/A | Lundbeck LLC | $167,954 | 0 |
| Evaluation of add-on treatment of adults with refractory localization related epilepsy with clobazam A pilot study | Lundbeck LLC | $92,600 | 0 |
| Clobazam Adjunctive Treatment of Adults With Refractory Focal Epilepsy | Lundbeck LLC | $46,000 | 0 |
| Treatment of Anxiety Comorbid with Epilepsy | Lundbeck LLC | $28,760 | 0 |
| A Retrospective Study Safety and efficacy of Clobazam in Children with Seizures Less Than Two Years of Age | Lundbeck LLC | $18,038 | 0 |
| Effects of Clobazam on sleep and daytime function in patients with epilepsy | Lundbeck LLC | $13,057 | 0 |
| Epilepsy Birth Control Registry - Full Prospective Study | Lundbeck LLC | $12,955 | 0 |
Top Doctors Receiving Payments for ONFI
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $379,385 | 11 |
| , M.D | Neurology | Fort Wayne, IN | $138,487 | 202 |
| Ahmed Abdelmoity | Neurology with Special Qualifications in Child Neurology | Kansas City, MO | $68,421 | 105 |
| , D.O | Neurology with Special Qualifications in Child Neurology | Cincinnati, OH | $37,763 | 80 |
| , M.D | Neurology | San Francisco, CA | $35,068 | 86 |
| , MD | Neurology | Houston, TX | $34,734 | 66 |
| , M.D | Neurology | Phoenix, AZ | $34,719 | 71 |
| , MD | Neurology | Nashville, TN | $33,439 | 63 |
| , MD | Clinical Neurophysiology | Los Angeles, CA | $31,567 | 42 |
| , MD | Neurology | Tampa, FL | $30,990 | 56 |
| , M.D | Neurodevelopmental Disabilities | Los Angeles, CA | $30,936 | 48 |
| , MD | Neurology | Mobile, AL | $24,416 | 41 |
| , MD | Clinical Neurophysiology | Chicago, IL | $24,170 | 40 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Saint Paul, MN | $23,826 | 29 |
| , MD | Neurology | Arcadia, CA | $20,920 | 51 |
| , M.D | Neurology with Special Qualifications in Child Neurology | Jacksonville, FL | $20,178 | 37 |
| , MD | Neurology | Lexington, KY | $19,685 | 37 |
| , MD PHD | Neurology | East Setauket, NY | $18,348 | 22 |
| , MD | Neurology | New York, NY | $18,236 | 63 |
| , MD | Neurology with Special Qualifications in Child Neurology | Memphis, TN | $17,523 | 29 |
| , DO | Vascular Neurology | Ocala, FL | $17,331 | 39 |
| , M.D | Neurology | Atlanta, GA | $17,294 | 33 |
| , MD | Neurology with Special Qualifications in Child Neurology | Miami, FL | $16,409 | 35 |
| , M.D | Neurology | Louisville, KY | $16,384 | 33 |
| , MD | Neurology | Cincinnati, OH | $15,043 | 24 |
Ad
Manufacturing Companies
- Lundbeck LLC $1.6M
Product Information
- Type Drug
- Total Payments $1.6M
- Total Doctors 3,130
- Transactions 12,867
About ONFI
ONFI is a drug associated with $1.6M in payments to 3,130 healthcare providers, recorded across 12,867 transactions in the CMS Open Payments database. The primary manufacturer is Lundbeck LLC.
Payment data is available from 2017 to 2024. In 2024, $24.91 was paid across 1 transactions to 1 doctors.
The most common payment nature for ONFI is "Honoraria" ($838,638, 51.6% of total).
ONFI is associated with 7 research studies, including "N/A" ($167,954).